San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Atyr Pharma Announces Q4, 2015 Financials, Names New CMO

aTyr Pharma, Inc., a biotherapeutics company in San Diego, announced fourth quarter and full-year earnings, along with the appointment of a new company executive.

Therapeutic at Center of Diagnostic Co. Dispute

BIOTECH: Trovagene Firings Raise Questions Over Roles

Is Trovagene Inc. a diagnostic or a therapeutic company?

Biotech Startup Zavante Therapeutics Raises $45 Million

Zavante Therapeutics, a San Diego startup quietly launched by big-shot biotech veterans last fall, has raised $45 million to fund development of its lead drug.

Fired Trovagene CEO Says He Will Sue for Wrongful Termination

Trovagene Inc. has fired and sued two of its top executives — CEO Antonius Schuh and CFO Stephen Zaniboni -- alleging breach of fiduciary duty. The actions caught both seasoned biotech executives by surprise.

Tease photo

FDA Panel Votes to Recommend ACADIA Pharmaceuticals Drug

The Food and Drug Administration's panel of advisers voted 12-2 Tuesday in favor of an experimental drug from ACADIA Pharmaceuticals, saying its benefits outweigh the risks.

Tease photo

Trovagene CEO, COO Fired; Sued for Breach of Fiduciary Duty

Trovagene’s shares are down 12 percent Tuesday after the maker of liquid biopsies said it fired and sued its chief executive officer and chief financial officer.

Neothetics Inc. Announces Plans to Commence Phase 2 Trial of Fat-Reducing Drug

San Diego’s Neothetics Inc. announced plans to move forward with its LIPO-202 program, despite earlier failed clinical trials and the abrupt resignation last month of CEO George Mahaffey.

Forge Therapeutics to Collaborate With Active Motif

San Diego’s Forge Therapeutics is teaming up with Carlsbad’s Active Motif on a research collaboration, the companies announced Monday.

DJO Reports $1.11 Billion in Net Sales for 2015

DJO Global Inc., a medical device company in San Diego, announced financial results for the fourth quarter and full 2015 year.

Imprimis Pharmaceuticals Reports Revenue Increase in Q4 and 2015

San Diego’s Imprimis Pharmaceuticals, a maker of compounded drugs, reported a significant increase in revenue for the fourth quarter and full 2015 year.

Tease photo

Device Maker Acutus Medical Receives $75M in Funding

BIOTECH: Carlsbad Co. Is Developing 3-D Imaging For Heart Procedures

Carlsbad medical device maker Acutus Medical Inc. closed a $75 million Series C round last week, one of the biggest infusions of cash the local medtech sector has seen in recent years.

TP Therapeutics Raises Nearly $18 Million in Series B Financing Round

TP Therapeutics, a small San Diego pharmaceutical company, has raised nearly $18 million in an all-equity Series B financing round, according to a recent form filed with the Securities and Exchange Commission.

HUYA's Founder/CEO Stepping Down

San Diego drugmaker HUYA Bioscience International announced that its founder and CEO, Mireille Gillings, is stepping down.

Acutus Medical Closes $75 Million Fundraising Round

Carlsbad medical device maker Acutus Medical has closed a $75 million Series C round, the company said Tuesday. The financing round came from Deerfield Management Company, Xeraya Capital and an undisclosed strategic investor, along with existing investor Advent Life Sciences, plus OrbiMed and GE Ventures.

Health Center Partners Expanding to Riverside County

Health Center Partners (HCP), a consortium of 17 primary care organizations in Southern California, is expanding its programs and investments to meet a growing demand in Riverside County.